SCHEMBL4633152

SCHEMBL4633152

COc1cc2c(c(OC)c1)C(=O)N(CCc1ccc(Cl)cc1)C2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHCR7 Q9UBM7 1/20 0.43
ACHE P22303 1/20 0.40
MAPT P10636 3/20 0.40
KCNA5 P22460 2/20 0.39
KCNH2 Q12809 1/20 0.39
NR1I2 O75469 1/20 0.39
MAOA P21397 1/20 0.39
PTGS2 P35354 1/20 0.39
OPRK1 P41145 1/20 0.39
SLC6A3 Q01959 1/20 0.39
ALDH1A1 P00352 4/20 0.39
LMNA P02545 2/20 0.39
HTT P42858 2/20 0.39
HPGD P15428 1/20 0.39
MAPK1 P28482 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ABCB1 P08183 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1002978 0.89 MEN1 (0.45) ACHEMAPTALDH1A1LMNAMAPK1
SCHEMBL12641861 0.79 ABCB1 (0.43) ACHEMAPTABCB1MEN1KMT2A
SCHEMBL12582003 0.78 ALDH1A1 (0.49) ACHEMAPTOPRK1ALDH1A1LMNA
SCHEMBL12582025 0.78 ALDH1A1 (0.45) PTGS2ALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL5242337 0.77 PARP1 (0.42) ACHEMAPTKCNH2ALDH1A1SMN1; SMN2
SCHEMBL12413548 0.77 MEN1 (0.45) ACHELMNASMN1; SMN2MEN1KMT2A
SCHEMBL8240557 0.77 ALDH1A1 (0.42) PTGS2ALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL2023264 0.76 MEN1 (0.44) ACHEMEN1KMT2ATSHR
SCHEMBL1003589 0.75 HCRTR1 (0.53)
SCHEMBL8272139 0.73 ACHE (0.39) ACHEMAPTALDH1A1HPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912940-A1 SUBSTITUTED ISOINDOLONES AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS AstraZeneca AB (SE) 2008-04-23 EP claimed
WO-2007021309-A1 SUBSTITUTED ISOINDOLONES AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS ASTRAZENECA AB (SE) 2007-02-22 WO claimed
EP-1912940-A1 SUBSTITUTED ISOINDOLONES AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS AstraZeneca AB (SE) 2008-04-23 EP disclosed
EP-1778634-A1 ISOINDOLONE COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS AstraZeneca AB (SE) 2007-05-02 EP disclosed
WO-2007021309-A1 SUBSTITUTED ISOINDOLONES AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS ASTRAZENECA AB (SE) 2007-02-22 WO disclosed
WO-2006020879-A1 ISOINDOLONE COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS ASTRAZENECA AB (SE) 2006-02-23 WO disclosed